Your Article Summary
See Latest ArticlesPredicting benefit from fulvestrant in pretreated metastatic breast cancer patients
Breast Cancer Research and Treatment, 06/29/09
Freedman O et al. - Factors predictive of being chemotherapy free at 3 months included older age, no prior adjuvant hormonal therapy, and the absence of lung or brain metastases at the start of therapy. A receiver operating characteristic (ROC) curve analysis had an area under the curve of 0.7
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 74%
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09
Relevance Score: 72%
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients
Breast Cancer Research and Treatment, 10/27/09
Relevance Score: 72%
Underweight and breast cancer recurrence and death: A report from the Korean breast cancer society
Journal of Clinical Oncology, 10/08/09
Relevance Score: 72%
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study
Cancer Epidemiology, Biomarkers & Prevention, 10/01/09
Relevance Score: 72%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
The relation of leptin and adiponectin with breast density among premenopausal women
European Journal of Cancer Prevention, 12/09/09
Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radiotherapy: A randomized controlled trial
Complementary Therapies in Medicine, 12/09/09
Gigantomastia in a patient with systemic lupus erythematosus successfully treated by reduction mammoplasty
Lupus, 12/09/09